Atlas Trials

Organotypic Platform for Therapeutic Investigation (OPTin) for Guiding Cancer Patients Treatment

Clinical trial NCT07468422 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07468422
Sponsor
China Medical University Hospital
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Cancer Patients With Solid TumorsCancer (Advanced Stage)
Start date
2025-10-27
Primary completion
2027-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.